CA Patent

CA2912902A1 — Polymorphic forms of nilotinib hydrochloride

Assigned to Dr Reddys Laboratories Ltd · Expires 2014-10-30 · 12y expired

What this patent protects

Crystalline Forms R5, R5a, R5b and R6 of nilotinib hydrochloride and processes for their preparation.

USPTO Abstract

Crystalline Forms R5, R5a, R5b and R6 of nilotinib hydrochloride and processes for their preparation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2912902A1
Jurisdiction
CA
Classification
—
Expires
2014-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.